Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer
Recruiting
- Conditions
- Ovarian Cancer
- Registration Number
- NCT05410015
- Lead Sponsor
- Peking Union Medical College Hospital
- Brief Summary
The relationship between immune inflammation-related protein complexes inblood and recurrence or metastasis of ovarian cancer will be studied
- Detailed Description
100 cases in normal ovarian control group, 100 cases in benign ovarian disease group and 100 cases in malignant ovarian epithelial carcinoma group will be studied. Change regularity of ovarian cancer specific immune inflammation-related protein complexes in blood will be studied. The relationship between disease-specific protein complexes and pathological state of patients will be analyzed.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 300
Inclusion Criteria
- Female
- Normal ovary control
- Ovarian benign disease
- Ovarian malignant epithelial carcinoma
Exclusion Criteria
- Male
- Age above 70
- Suffering from other malignant tumors
- Non-compliant patient
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immune Inflammation-Related Protein Pomplexes 2 years The change of immune inflammation-related protein complexes
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Peking Union Medical College Hospital
🇨🇳Beijing, Beijing, China